Concepedia

Author

José Thomas

KU LeuvenORCID

Also Known As

J A B Thomas, J A Thomas, J THOMAS, J Thomas, J. A. B. Thomas, J. A. Thomas, J. THOMAS, J. Thomas, Jose Thomas, José Thomas

114

Publications

7K

Citations

44

H-Index

61

Concepts

All Affiliations

KU LeuvenInstitut Gustave RoussyUniversitair Ziekenhuis LeuvenThe Netherlands Cancer InstituteCentro di Riferimento Oncologico
JT

About

José Thomas is an author at KU Leuven specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

27

1.8K

2

Health Sciences

12

12

977

3

Social Sciences

1

1

29

4

Cell Biology

1

1

17

5

Geriatrics

1

1

109

José Thomas

×

66

Publications

6.9K

Citations

44

H-Index

YearCitations

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([<sup>18</sup>F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [<sup>18</sup>F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont,

Journal of Clinical Oncology

2001

466

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt,

New England Journal of Medicine

2007

444

Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont,

Annals of Oncology

2002

409

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Philip Poortmans, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche,

Journal of Clinical Oncology

2003

331

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli,

New England Journal of Medicine

2003

306

Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features [see comments]

Judith Dierlamm, Stefania Pittaluga, M.S Stul,

Blood

1996

263

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

M Tubiana, M. Henry‐Amar, Patrice Carde,

Blood

1989

261

Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials

Evert M. Noordijk, Patrice Carde, N. Dupouy,

Journal of Clinical Oncology

2006

229

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont,

Blood

2003

225

CHOP is the standard regimen in patients &gt; or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

Umberto Tirelli, D. Errante, M. van Glabbeke,

Journal of Clinical Oncology

1998

219

Page 1